David Y. Rhee

David Y. Rhee

Auto-generated profile, based on publicly available information

David Y. Rhee

Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in Cell
Verified
Journal Article
Closed access
KGK.G. Guruharsha
K.G. Guruharsha
Jean-Francois RualJean-Francois Rual
Jean-Francois Rual
BZBo Zhai
Bo Zhai
JMJulian Mintseris
Julian Mintseris
PVPujita Vaidya
Pujita Vaidya
SASpyros Artavanis-Tsakonas
Spyros Artavanis-Tsakonas

5 July 2019 in Science
Verified
Journal Article
Closed access
PDF file
RTRichard T. Timms
Richard T. Timms
ZZZhiqian Zhang
Zhiqian Zhang
DRDavid Y. Rhee
David Y. Rhee
JHJ. Wade Harper
J. Wade Harper
IKItay Koren
Itay Koren
SEStephen J. Elledge
Stephen J. Elledge
Glycine N-degron regulation revealed: For more than 30 years, N-terminal sequences have been known to influence protein stability, but additional features of these N-end rule, or N-degron, pathways continue to be uncovered. Timms et al. used a global protein stability (GPS) technology to take a broader look at these pathways in human cells. Unexpectedly, glycine exposed at the N terminus could act as a potent degron; proteins bearing N-terminal glycine were targeted for proteasomal degradation by two Cullin-RING E3 ubiquitin ligases through the substrate adaptors ZYG11B and ZER1. This pathway may be important, for example, to degrade proteins that fail to localize properly to cellular membranes and to destroy protein fragments generated during cell death. Science , this issue p. eaaw4912

1 August 2016 in Cell
Verified
Journal Article
Closed access
DSDaniel C. Scott
Daniel C. Scott
DRDavid Y. Rhee
David Y. Rhee
DDDavid M. Duda
David M. Duda
IKIan R. Kelsall
Ian R. Kelsall
JOJennifer L. Olszewski
Jennifer L. Olszewski
BSBrenda A. Schulman
Brenda A. Schulman

5 June 2017 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
DSDaniel C Scott
Daniel C Scott
JHJared T Hammill
Jared T Hammill
JMJaeki Min
Jaeki Min
DRDavid Y Rhee
David Y Rhee
MCMichele Connelly
Michele Connelly
RGR Kip Guy
R Kip Guy
High-throughput screening and structure-guided design identified small-molecule inhibitors that prevent the interaction between N-terminally acetylated E2 conjugating enzyme UBE2M and DCN1, an E3 ligase for the ubiquitin-like protein Nedd8. N-terminal acetylation is an abundant modification influencing protein functions. Because ∼80% of mammalian cytosolic proteins are N-terminally acetylated, this modification is potentially an untapped target for chemical control of their functions. Structural studies have revealed that, like lysine acetylation, N-terminal acetylation converts a positively charged amine into a hydrophobic handle that mediates protein interactions; hence, this modification may be a druggable target. We report the development of chemical probes targeting the N-terminal acetylation–dependent interaction between an E2 conjugating enzyme (UBE2M or UBC12) and DCN1 (DCUN1D1), a subunit of a multiprotein E3 ligase for the ubiquitin-like protein NEDD8. The inhibitors are highly selective with respect to other protein acetyl-amide–binding sites, inhibit NEDD8 ligation in vitro and in cells, and suppress anchorage-independent growth of a cell line with DCN1 amplification. Overall, our data demonstrate that N-terminal acetyl-dependent protein interactions are druggable targets and provide insights into targeting multiprotein E2–E3 ligases.

1 September 2014 in Cell Reports
Verified
Journal Article
Open access
DRDavid Y. Rhee
David Y. Rhee
DCDong-Yeon Cho
Dong-Yeon Cho
BZBo Zhai
Bo Zhai
MSMatthew Slattery
Matthew Slattery
LMLijia Ma
Lijia Ma
SASpyros Artavanis-Tsakonas
Spyros Artavanis-Tsakonas
Specific cellular fates and functions depend on differential gene expression, which occurs primarily at the transcriptional level and is controlled by complex regulatory networks of transcription factors (TFs). TFs act through combinatorial interactions with other TFs, cofactors, and chromatin-remodeling proteins. Here, we define protein-protein interactions using a coaffinity purification/mass spectrometry method and study 459 Drosophila melanogaster transcription-related factors, representing approximately half of the established catalog of TFs. We probe this network in vivo, demonstrating functional interactions for many interacting proteins, and test the predictive value of our data set. Building on these analyses, we combine regulatory network inference models with physical interactions to define an integrated network that connects combinatorial TF protein interactions to the transcriptional regulatory network of the cell. We use this integrated network as a tool to connect the functional network of genetic modifiers related to mastermind, a transcriptional cofactor of the Notch pathway.

19 January 2023 in ACS Chemical Biology
Verified
Journal Article
Closed access
ASAndrea G. Shergalis
Andrea G. Shergalis
VMVioleta L. Marin
Violeta L. Marin
DRDavid Y. Rhee
David Y. Rhee
SSSameera Senaweera
Sameera Senaweera
RMRebecca L. McCloud
Rebecca L. McCloud
JRJustin M. Reitsma
Justin M. Reitsma